0001348362-16-000006.txt : 20160913 0001348362-16-000006.hdr.sgml : 20160913 20160913130535 ACCESSION NUMBER: 0001348362-16-000006 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20160913 DATE AS OF CHANGE: 20160913 EFFECTIVENESS DATE: 20160913 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lexaria Bioscience Corp. CENTRAL INDEX KEY: 0001348362 STANDARD INDUSTRIAL CLASSIFICATION: METAL MINING [1000] IRS NUMBER: 202000871 STATE OF INCORPORATION: NV FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-270509 FILM NUMBER: 161882493 BUSINESS ADDRESS: STREET 1: SUITE 950, 1130 WEST PENDER STREET CITY: VANCOUVER STATE: A1 ZIP: V6E 4A4 BUSINESS PHONE: 604-602-1675 MAIL ADDRESS: STREET 1: SUITE 950, 1130 WEST PENDER STREET CITY: VANCOUVER STATE: A1 ZIP: V6E 4A4 FORMER COMPANY: FORMER CONFORMED NAME: LEXARIA CORP. DATE OF NAME CHANGE: 20080229 FORMER COMPANY: FORMER CONFORMED NAME: Lexaria Corp. DATE OF NAME CHANGE: 20051229 D 1 primary_doc.xml X0707 D LIVE 0001348362 Lexaria Bioscience Corp. SUITE 950, 1130 WEST PENDER STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA V6E 4A4 604-602-1675 NEVADA LEXARIA CORP. Lexaria Corp. Corporation true Christopher Bunka Suite 950 1130 West Pender Street Vancouver A1 BRITISH COLUMBIA, CANADA V6E 4A4 Executive Officer Director John Martin Docherty Suite 950 1130 West Pender Street Vancouver A1 BRITISH COLUMBIA, CANADA V6E 4A4 Executive Officer Director Nicholas W. Baxter 220 Springfield Road Aberdeen, Scotland X0 UNITED KINGDOM AB15 6AU Director Ted McKechnie 305 Margaret Avenue Suite 707 Kitchener A6 ONTARIO, CANADA N2H 6S4 Director Pharmaceuticals $1 - $1,000,000 06c false 2016-08-31 false true true false 10500 108500 108500 0 false 6 0 0 0 false Lexaria Bioscience Corp. /s/Chris Bunka Chris Bunka CEO/Director 2016-09-13